0002047647-24-000001.txt : 20241206 0002047647-24-000001.hdr.sgml : 20241206 20241206112527 ACCESSION NUMBER: 0002047647-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241206 DATE AS OF CHANGE: 20241206 EFFECTIVENESS DATE: 20241206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 65 Therapeutics, Inc. CENTRAL INDEX KEY: 0002047647 ORGANIZATION NAME: IRS NUMBER: 994832896 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-531309 FILM NUMBER: 241531141 BUSINESS ADDRESS: STREET 1: 399 REVOLUTION DRIVE CITY: SOMERVILLE STATE: MA ZIP: 02145 BUSINESS PHONE: 617-784-9147 MAIL ADDRESS: STREET 1: 399 REVOLUTION DRIVE CITY: SOMERVILLE STATE: MA ZIP: 02145 D 1 primary_doc.xml X0708 D LIVE 0002047647 65 Therapeutics, Inc. 399 REVOLUTION DRIVE SOMERVILLE MA MASSACHUSETTS 02145 617-784-9147 DELAWARE None None Corporation true 2024 Julius Knowles c/o 65 Therapeutics, Inc. 399 Revolution Drive Somerville MA MASSACHUSETTS 02145 Executive Officer Director Murthy Chavali c/o 65 Therapeutics, Inc. 399 Revolution Drive Somerville MA MASSACHUSETTS 02145 Director Pharmaceuticals Decline to Disclose 06b false 2024-11-21 false true false 0 5500000 4500000 1000000 false 2 0 0 0 false 65 Therapeutics, Inc. /s/ Julius Knowles Julius Knowles President 2024-12-04